Dirk Lange
Merck Becomes First CTDMO to Offer Comprehensive mRNA Development and Manufacturing Services
Dirk T. Lange - MilliporeSigma | LinkedIn
Say hello to a “CTDMO” - Molecule to Market
MilliporeSigma Reorganizes And Adopts New Operating Model | Contract Pharma
Dirk T. Lange on LinkedIn: Today marks a new chapter for me as I join an organization with so much… | 209 comments
Merck agrandit son dernier centre d'essais biologiques à Shanghai - Développement de ses laboratoires d'essais de biosécurité pour répondre à la demande locale
Dirk Lange Reveals Merck's Historic Leap as the First CTDMO to Offer Integrated mRNA Services: A Blueprint for Advancing Biopharma
Dirk T. Lange on LinkedIn: One of our strategic priorities continues to be strengthening our…
Merck increases global commitment to biosafety testing with €35 million investment in Scotland | Glasgow Chamber of Commerce
CDMO : Merck va doubler sa production d'HPAPI aux États-Unis
Q&A: Dirk Lange, president and CEO of KBI Biopharma, talks about biotech growth in The Woodlands | Community Impact
Équipe dirigeante
Merck Life Science on X: "The battle against cancer is long and arduous. However, HPAPIs, or Highly Potent Active Pharmaceutical Ingredients, can be a powerful weapon against cancer. Hear from our Head
Dirk T. Lange on LinkedIn: Dirk Lange Reveals Merck's Historic Leap as the First CTDMO to Offer… | 12 comments
Dirk T. Lange - MilliporeSigma | LinkedIn
Dirk Lange - Head of Operations, External Supply Operations, Novartis Biologics - Novartis Pharma AG | XING
Dirk T. Lange on LinkedIn: Biologics Testing Center Shanghai - News | Merck KGaA, Darmstadt, Germany
Dirk T. Lange - MilliporeSigma | LinkedIn
MilliporeSigma Announces Organizational Transformation to Strengthen CDMO Offering and Accelerate Future Growth
Équipe dirigeante
Dirk Lange
Équipe dirigeante
Merck restructures to strengthen CDMO business
